I.V. Treatments Offer Diabetics Increased Circulation and Improved Eye Health

The following is a reproduction of a Millennium Health Centre editorial article which appeared in the Seaway News newspaper in Cornwall, Ontario, Canada. The content is shortened to accommodate a newspaper space allotment. As such, it is not academically cited with references. These are available, so please feel free to email your questions.


Dr. Stephen F. Jones B.Comm., N.D.
Doctor of Naturopathic Medicine

Recently, several medical doctors and optometrists contacted myself asking about treatment options for their diabetic patients. Specifically, these doctors wanted to know if any therapies were available to treat the 'macular degeneration' (a type of eye disease) and impaired circulation often experienced by diabetic patients. As rates of diabetes are rapidly increasing, I thought I might share the information provided to these physicians.

With respect to macular degeneration, the exciting news is that numerous biochemical considerations exist. As illustration of this fact, many optometrists and ophthalmologists routinely advised their patients to take a basic multivitamin. On occasion, they will even encourage the use herbs like 'Bilberry' or nutrients like 'Lutein'. The reason is that these nutrients have clear research demonstrating their role in treating eye conditions.

As a brief illustration, the nutrient Lutein is found in great quantity in the macula of the eye and supplementation with Lutein has been found to reduce oxidative damage of the macula (Archives of Ophthalmology Jan. 1993;111:104-9). As such, supplementing with Lutein is thought to reduce the degree of future oxidative damage and possibly reverse existing damage to the macula.

Similarly, the nutrient Taurine is know to act as a potent antioxidant within the eye, scavenging free radical damage caused by industrial pollutants etc., (Journal of Advancement in Medicine 1996;9:179-199). Likewise, the mineral Zinc has long been shown in studies to cause a 25 % reduction in the development of age-related macular degeneration with the use of the right therapeutic dose (Archives of Ophthalmology 2001;119:1417-1436).

So, while many other 'natural' medical options could be discussed, the point is that the very sensitive tissues of the eye can be profoundly benefited by administration of the right dose of these nutrients. The challenge, however, is that it is not easy to get the right dose of these nutrients actually absorbed into the bloodstream and delivered to the tissue of the eye to provide the therapeutic effect. Oral supplements (pills) not only have insufficient dosages, they are greatly limited by the body's ability to digest and absorb them into the blood stream, especially in seniors and some diabetics.

The good news is that specific intravenous (I.V.) protocols exist to treat macular degeneration. In using these I.V. therapies, the patient is provided with the right dosages of all researched nutrients, administered straight into the blood supply, allowing for a faster and more efficient therapeutic effect.

I.V. treatments can do considerably more, however, than simply provide critical nutrients. Certain therapies can also dramatically increase the circulation of blood throughout the body, reversing impaired flow to tissues of not only the eye, but the extremities. Decreases in blood flow to extremities like the lower legs, ankles and feet are one reason why many diabetics suffer tissue degeneration, impaired wound healing and even (in extreme cases) gangrenous infections at these locations.

'Chelation therapy' is a focal treatment of consideration. This treatment has numerous studies illustrating its ability to increase blood flow through blocked or narrowed vessels. Between the years of 1964 to 1968 several studies were published on the use of chelation in the treatment of diabetic circulatory diseases. Every trial demonstrated improved circulation after the use of chelation therapy (as published in the journals Angiology 1964, 15:379-394, Journal of American Geriatric Society 1966;14:272-294 and presented to the American College of Angiology conference in 1968).

Similarly, a 1988 study revealed that 91% of patients with 'peripheral vascular disease' (impaired circulation) had a 'marked improvement' after chelation therapy (Medical Hypothesis, 1988;27:41-49). While many other studies could be cited, space does not allow.

Since a past column has already discussed Chelation in detail, I will refer reader's interested in chelation to my website's "Links" section. In addition, a worthwhile read on the subject is 'Bypassing Bypass Surgery' by Dr. Cranton M.D.

Diabetics require an integrated approach in controlling their condition and minimizing its side effects. Fortunately, several I.V. therapies exist to not only treat their eye health concerns, but also their impaired circulation, any loss of sensation (neuropathy) and even to control their blood sugar without increased medication. As always, patients must take control of their own health and seek options.

Best of health to you.

Readers may write the EMC newspaper or email Dr. Jones at with any inquiries.